Dry Eye Syndrome
Showing NaN - NaN of 6
Dry Eye Syndrome Trial in United States (Low Dose - SkQ1, High dose - SkQ1, SkQ1 (Vehicle))
Completed
- Dry Eye Syndrome
- Low Dose - SkQ1
- +2 more
-
Phoenix, Arizona
- +6 more
Dec 20, 2021
Dry Eye Syndrome, Keratoconjunctivitis Sicca Trial in United States (0.05% Voclosporin Ophthalmic Solution (VOS), 0.10% VOS,
Completed
- Dry Eye Syndrome
- Keratoconjunctivitis Sicca
- 0.05% Voclosporin Ophthalmic Solution (VOS)
- +3 more
-
Newport Beach, California
- +8 more
Dec 8, 2021
Dry Eye Syndrome Trial in United States (BRM421, Placebo)
Dry Eye Syndrome Trial in United States (TOP1630 0.1% Ophthalmic Solution TID OU, Placebo to TOP1630 0.1% Ophthalmic Solution
Completed
- Dry Eye Syndrome
- TOP1630 0.1% Ophthalmic Solution TID OU
- Placebo to TOP1630 0.1% Ophthalmic Solution TID OU
-
Lewiston, Maine
- +3 more
Aug 6, 2019
Dry Eye Syndrome Trial in United States (Reproxalap Ophthalmic Solution (0.25%), Reproxalap Ophthalmic Solution (0.1%), Vehicle
Completed
- Dry Eye Syndrome
- Reproxalap Ophthalmic Solution (0.25%)
- +2 more
-
Waterbury, Connecticut
- +5 more
Jul 10, 2019
Dry Eye Syndrome Trial in United States (Rebamipide 2% ophthalmic suspension, Placebo (vehicle))
Completed
- Dry Eye Syndrome
- Rebamipide 2% ophthalmic suspension
- Placebo (vehicle)
-
Phoenix, Arizona
- +33 more
Apr 17, 2014